Objective: The study aimed to determine the factors associated with the use of traditional, complementary and alternative medicine (TCAM) methods of women who applied to a mammography unit. Material and Methods: The descriptive study was carried out on 198 volunteer female patients. The data were obtained through a questionnaire form created by the researchers. Chi-square test was used in statistical analyses and p values lower than 0.05 were considered statistically significant. The required local ethics committee approval was obtained. Results: The mean age of the patients was 49.2±12.8 years, 29.3% applied for mammography screening and 70.7% applied for a control examination. The frequency of those who used any TCAM method was 47.5%. At the time of their initial diagnosis, 33% of the patients used TCAM during the treatment process. When comparing the sociodemographic features, reasons for admission, diagnosis times, and treatment methods of the used and non-used TCAM classes, no statistically significant differences were observed (p>0.05). And 60.0% of breast cancer patients who used TCAM and 81.3% of those with fibroadenome or breast cysts did not share information with their physicians that they used TCAM. Conclusion: Regardless of sociodemographic characteristics or breast disease diagnosis, it was determined that approximately half of the women who applied to the mammography unit used a TCAM method at any time in their lives. Considering that some TCAM methods can lead to diagnosis and treatment delays, we think that physicians questioning the use of TCAM in their patients should become a routine part of the examination.
Keywords: Traditional and complementary medicine; alternative medicine; herbal medicine; breast cancer; breast mass
Amaç: Çalışmada, mamografi ünitesine başvuran kadınların geleneksel, tamamlayıcı ve alternatif tıp (GETAT) yöntemi kullanma durumları ile ilişkili faktörlerin belirlenmesi amaçlanmıştır. Gereç ve Yöntemler: Tanımlayıcı tipteki çalışma, 198 gönüllü kadın hasta üzerinde yürütüldü. Veriler, araştırmacılar tarafından oluşturulan bir anket formu aracılığıyla elde edildi. İstatistiksel analizlerde ki-kare testi kullanıldı ve anlamlılık düzeyi p0,05). GETAT kullanan meme kanseri hastalarının %60,0'ı, fibroadenomu veya memede kisti olanların %81,3'ü GETAT kullandıkları bilgisini hekimleriyle paylaşmamıştı. Sonuç: Sosyodemografik özellikleri ya da meme hastalığı tanısından bağımsız olarak, mamografi ünitesine başvuran kadınların yaklaşık yarısının bir GETAT yöntemi kullandığı belirlendi. Bazı GETAT yöntemlerinin tanı ve tedavi gecikmelerine yol açabileceği dikkate alındığında, hekimlerin hastalarında GETAT kullanımını sorgulamasının muayenenin rutin bir parçası hâline gelmesi gerektiğini düşünüyoruz.
Anahtar Kelimeler: Geleneksel ve tamamlayıcı tıp; alternatif tıp; bitkisel tedavi; meme kanseri; memede kitle
- World Health Organization [Internet]. © 2022 WHO [Cited: January 18, 2022]. WHO traditional medicine strategy: 2014-2023. Available from: [Link]
- Bodeker G, Kronenberg F. A public health agenda for traditional, complementary, and alternative medicine. Am J Public Health. 2002;92(10):1582-91. [Crossref] [PubMed] [PMC]
- National Center for Complementary and Integrative Health [Internet]. [Cited: January 18, 2022]. Complementary, Alternative, or Integrative Health: what's in a Name? Available from: [Link]
- Akhtar K, Akhtar K, Rahman MM. Use of alternative medicine is delaying health-seeking behavior by Bangladeshi breast cancer patients. Eur J Breast Health. 2018;14(3):166-72. [Crossref] [PubMed] [PMC]
- Horneber M, Bueschel G, Dennert G, Less D, Ritter E, Zwahlen M. How many cancer patients use complementary and alternative medicine: a systematic review and metaanalysis. Integr Cancer Ther. 2012;11(3):187-203. [Crossref] [PubMed]
- Harris PE, Cooper KL, Relton C, Thomas KJ. Prevalence of complementary and alternative medicine (CAM) use by the general population: a systematic review and update. Int J Clin Pract. 2012;66(10):924-39. [Crossref] [PubMed]
- Peltzer K, Pengpid S. Prevalence and determinants of traditional, complementary and alternative medicine provider use among adults from 32 countries. Chin J Integr Med. 2018;24(8):584-90. [Crossref] [PubMed]
- Oral B, Öztürk A, Balcı E, Sevinç N. Aile sağlığı merkezine başvuranların geleneksel/alternatif tıpla ilgili görüşleri ve kullanım durumu [State of opinions and use about traditional/alternative medicine who applied to family health center]. TAF Prev Med Bull. 2016;15(2):75-82. [Crossref]
- Turan N, Öztürk A, Kaya N. Hemşirelikte yeni bir sorumluluk alanı: tamamlayıcı terapi [A new responsibility in nursing: complementary therapy]. Maltepe Univ J Nurs Sci Art. 2010;3(1):103-8. [Link]
- Şimşek B, Aksoy DY, Basaran NC, Taş D, Albasan D, Kalaycı MZ. Mapping traditional and complementary medicine in Turkey. Eur J Integr Med. 2017;15:68-72. [Crossref]
- Busato A, Dönges A, Herren S, Widmer M, Marian F. Health status and health care utilisation of patients in complementary and conventional primary care in Switzerland--an observational study. Fam Pract. 2006;23(1):116-24. [Crossref] [PubMed]
- Farhoudi F, Salehi A, Vojoud M, Molavi Vardanjani H. Assessment of the complementary and integrative medicine utilization among patients with multiple sclerosis using a translated and adapted version of the international questionnaire (I-CAM-QP): A cross-sectional study in Southern Iran. Complement Ther Med. 2019;46:47-53. [Crossref] [PubMed]
- Kav S, Hanoğlu Z, Algier L. Türkiye'de kanserli hastalarda tamamlayıcı ve alternatif tedavi yöntemlerinin kullanımı: literatür taraması [Use of complementary and alternative medicine by cancer patients in Turkey: a literature review]. UHOD. 2008;18(1):32-8. [Link]
- Kurt H, Keşkek ŞÖ, Çil T, Canataroğlu A. Meme kanserli hastalarda tamamlayıcı/alternatif tedavi kullanımı [Complementary/alternative therapies in patients with breast cancer]. Turkish Journal of Oncology. 2013;28(1):10-5. [Crossref]
- Karahancı ON, Öztoprak ÜY, Ersoy M, Ünsal ÇZ, Hayırlıdağ M, Büken NÖ. Geleneksel ve Tamamlayıcı Tıp Uygulamaları Yönetmeliği ile Yönetmelik Taslağı'nın karşılaştırılması [Comparison of Traditional, Complementary Medicine Draft Regulations and Regulations]. Turkish Journal of Bioethics. 2015;2(2):117-26. [Crossref]
- Falci L, Shi Z, Greenlee H. Multiple chronic conditions and use of complementary and alternative medicine among US adults: results from the 2012 national health interview survey. Prev Chronic Dis. 2016;13:E61. [Crossref] [PubMed] [PMC]
- Meriçli F. Sağlığımız için tibbi bitkiler ve bitkisel ilaçlar [Medicinal plants and herbal medicines for health]. BARNAT-Bilimsel Tamamlayıcı Tıp Regülasyon ve Nöral Terapi Dergisi. 2017;11(2):12-5. [Link]
- Aker S, Öz H, Tunçel EK. Practice of breast cancer early diagnosis methods among women living in Samsun, and factors associated with this practice. J Breast Health. 2015;11(3):115-22. [Crossref] [PubMed] [PMC]
- Yavuz M, İlçe AÖ, Kaymakçı Ş, Bildik G, Dıramalı A. Meme kanserli hastaların tamamlayıcı ve alternatif tedavi yöntemlerini kullanma durumlarının incelenmesi [Examination of the complementary and alternative treatment use with breast cancer patients]. Turkiye Klinikleri J Med Sci. 2007;27(5):680-6. [Link]
- Can G, Erol O, Aydiner A, Topuz E. Quality of life and complementary and alternative medicine use among cancer patients in Turkey. Eur J Oncol Nurs. 2009;13(4):287-94. [Crossref] [PubMed]
- Kemppainen LM, Kemppainen TT, Reippainen JA, Salmenniemi ST, Vuolanto PH. Use of complementary and alternative medicine in Europe: Health-related and sociodemographic determinants. Scand J Public Health. 2018;46(4):448-55. [Crossref] [PubMed] [PMC]
- Ray J, Chakrabarty D, Paul R, Som K. Prevalence of the use of complementary and alternative medicine in an eastern Indian population with emphasis on tribal/ethnic minority groups. J Taibah Univ Med Sci. 2018;13(4):384-9. [Crossref] [PubMed] [PMC]
- Toivonen KI, Tamagawa R, Speca M, Stephen J, Carlson LE. Open to exploration? Association of personality factors with complementary therapy use after breast cancer treatment. Integr Cancer Ther. 2018;17(3):785-92. [Crossref] [PubMed] [PMC]
- Gröchenig HP, Waldhör T, Haas T, Wenzl H, Steiner P, Koch R, et al; Austrian IBD Study Group (ATISG). Prevalence and indicators of use of complementary and alternative medicine in Austrian patients with inflammatory bowel disease. Eur J Gastroenterol Hepatol. 2019;31(10):1211-9. [Crossref] [PubMed]
- Boing AC, Ribeiro Santiago PH, Tesser CD, Furlan IL, Bertoldi AD, Boing AF. Prevalence and associated factors with integrative and complementary practices use in Brazil. Complement Ther Clin Pract. 2019;37:1-5. [Crossref] [PubMed]
- Wanchai A, Armer JM, Stewart BR. Complementary and alternative medicine use among women with breast cancer: a systematic review. Clin J Oncol Nurs. 2010;14(4):E45-55. [Crossref] [PubMed]
- Leach MJ. Profiling the Australian consumer of complementary and alternative medicine: a secondary analysis of national health survey data. Altern Ther Health Med. 2016;22(4):64-72. [PubMed]
- McQuade JL, Meng Z, Chen Z, Wei Q, Zhang Y, Bei W, et al. Utilization of and attitudes towards traditional chinese medicine therapies in a Chinese cancer hospital: a survey of patients and physicians. Evid Based Complement Alternat Med. 2012;2012:504507. [Crossref] [PubMed] [PMC]
- Grady I, Gorsuch H, Wilburn-Bailey S. Long-term outcome of benign fibroadenomas treated by ultrasound-guided percutaneous excision. Breast J. 2008;14(3):275-8. [Crossref] [PubMed]
- Kocabaş D, Erdal E, Demir M. Sağlık hizmeti kullanımında bireylerin geleneksel ve alternatif yöntemlere ilişkin tutumlarının değerlendirilmesi [Evaluation of the attitudes of the individuals on traditional and alternative methods in the use of health care]. BAİBÜ Sosyal Bilimler Enstitüsü Dergisi. 2019;19(1):63-80. [Crossref]
- Turkish Medical Oncology Association [Internet]. [Cited: January 18, 2022]. Complementary and Alternative Medicine. Available from: [Link]
.: Process List